Zephyr AI Secures $111M in Series A Funding to Revolutionize Healthcare with AI
Zephyr AI, a US-based healthcare technology company, has successfully raised $111 million in a Series A [...]
FDA Outlines Regulatory Framework for AI in Medical Products
The FDA has published a comprehensive plan to regulate artificial intelligence (AI) in medical products, marking [...]
The Experimental Quest for Longevity: Rapamycin’s Rising Popularity
At 77, David Sandler from Bergen County, N.J., has ventured into an experimental approach to longevity [...]
AstraZeneca Boosts Rare Diseases Portfolio with Acquisition of Amolyt Pharma
AstraZeneca has announced a definitive plan on Thursday, March 14 to acquire Amolyt Pharma, a clinical-stage [...]
FDA Approves First Drug for Fatty Liver Disease by Madrigal Pharmaceuticals
The FDA has approved Madrigal Pharmaceuticals' Rezdiffra, the first treatment for metabolic dysfunction-associated steatohepatitis (MASH), offering [...]
President Biden’s State of the Union: A Focus on Healthcare, Drug Pricing, and Reproductive Rights Amid Election Season
In his State of the Union address, President Joe Biden highlighted healthcare as a central priority, [...]
Biden Administration Proposes Increased FDA Funding for FY 2025 to Enhance Innovation and Health Services
Just days after the FDA’s fiscal year 2024 appropriations package was passed, the Biden administration is [...]
FDA Delays Approval of Eli Lilly’s Alzheimer’s Drug Donanemab, Citing Safety and Efficacy Concerns
Eli Lilly's Alzheimer's drug donanemab faces delays in FDA approval due to concerns over safety and [...]
Beyfortus: A New Milestone in RSV Prevention for Young Children
Beyfortus, a newly developed monoclonal antibody product by AstraZeneca and Sanofi, has shown a remarkable 90% [...]
GLP-1 RA Use Linked to Increased Residual Gastric Content in Fasted Patients
A cross-sectional study involving 124 fasted patients undergoing elective procedures under anesthesia revealed that users of [...]
Boundless Bio Eyes Nasdaq with Innovative Cancer Treatment Approach
Boundless Bio, a San Diego-based biotech startup, has announced its intention to go public on the [...]
The Stigma and Systemic Barriers Against Lifesaving Opioid Addiction Treatments in the U.S.
The opioid overdose epidemic has been devastating the U.S. for nearly three decades despite the availability [...]
Biden Administration Progresses on Lowering Drug Prices Amid Legal and Political Challenges
The Biden Administration announced continued progress in its campaign to reduce drug prices, highlighting that all [...]
Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues
Researchers in the U.K. have made a significant discovery in fetal health research by identifying viable [...]
Major US Pharmacy Chains to Offer Abortion Pill Mifepristone
CVS and Walgreens, the two largest pharmacy chains in the United States, announced plans to dispense [...]
Pfizer’s Strategic Oncology Expansion Post-Seagen Acquisition
Pfizer aims to bolster its oncology portfolio by targeting at least eight cancer blockbuster drugs by [...]
Biden Orders to Halt Foreign Data Collection; Congress Targets Chinese Biotech
President Joe Biden issued an executive order to prevent "countries of concern," notably China and related [...]
UK Intensifies Childhood Vaccination Efforts Amid Measles Outbreak
The UK is confronting an escalating measles outbreak by launching an advertising campaign to encourage childhood [...]
Global Cholera Vaccine Shortage: A Crisis Amplified
The world faces an unprecedented cholera vaccine shortage amidst surging outbreaks across developing nations in Asia, [...]
Alabama Ruling on Frozen Embryos Raises Concerns for Cancer Patients and Fertility Treatments
The Alabama Supreme Court's recent decision to classify frozen embryos as children under the law has [...]
Johnson & Johnson Shuts Down Brisbane R&D Center Amid Strategic Shift
Johnson & Johnson (J&J) is closing its nearly 200,000 square-foot research and development (R&D) outpost in [...]
Colorado Tests State Power on Drug Pricing
Colorado’s prescription drug affordability board is considering capping the cost of Amgen’s autoimmune medication Enbrel, marking [...]
Alabama Supreme Court Ruling Redefines Embryos as Children, Impacting Fertility Treatment
In a landmark decision, the Alabama Supreme Court has ruled that embryos destroyed in a bizarre [...]
“EveryBODY Covered”: Campaign Advocates for Comprehensive Obesity Care Coverage for Women
The Alliance for Women’s Health and Prevention (AWHP) has launched the “EveryBODY Covered” campaign, with support [...]
Pharma Companies Respond to FTC Patent Challenges with Delistings
Three pharmaceutical companies—GSK, Kaléo, and Amneal—have agreed to delist several patents in response to the Federal [...]